Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.03% Bimatoprost in Glaucoma and Ocular Hypertension
NCT02020512Phase 4Completed
- Sponsor
- Allergan
- Start
- Jul 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bimatoprost in Open-angle glaucoma (OAG) and ocular hypertension, sponsored by Allergan. Primary endpoint: Change From Baseline in Intraocular Pressure (IOP) in the Study Eye at 5 weeks. Started Jul 2011; status: completed.
02
Drugs
bimatoprost
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02020512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020512.